abstract |
Provided are an anti-CD39 antibody, an antigen-binding fragment thereof, and a medical use thereof, further provided are a chimeric antibody and a humanized antibody comprising a CDR region of the antibody, a pharmaceutical composition comprising the anti-CD39 antibody and the antigen-binding fragment thereof, and a use of the antibody in the preparation of a drug for the treatment of a disease or condition. The antibody can specifically bind to CD39, exhibits a good tumor growth inhibitory effect and is safe. |